NCT00043914View on ClinicalTrials.gov

Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy

PHASE4CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

January 14, 2002

Primary Completion Date

January 29, 2003

Study Completion Date

January 29, 2003

Conditions

Epilepsy

Interventions

DRUG

lamotrigine

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY